LeMaitre Vascular, Inc. (LMAT): Price and Financial Metrics
LMAT Price/Volume Stats
| Current price | $64.91 | 52-week high | $68.06 |
| Prev. close | $64.02 | 52-week low | $40.82 |
| Day low | $63.38 | Volume | 132,400 |
| Day high | $65.35 | Avg. volume | 96,650 |
| 50-day MA | $57.46 | Dividend yield | 0.89% |
| 200-day MA | $50.42 | Market Cap | 1.44B |
LMAT Stock Price Chart Interactive Chart >
LMAT POWR Grades
- LMAT scores best on the Growth dimension, with a Growth rank ahead of 94.42% of US stocks.
- The strongest trend for LMAT is in Value, which has been heading down over the past 179 days.
- LMAT's current lowest rank is in the Momentum metric (where it is better than 15.05% of US stocks).
LMAT Stock Summary
- With a price/earnings ratio of 64.53, LEMAITRE VASCULAR INC P/E ratio is greater than that of about 91.63% of stocks in our set with positive earnings.
- Price to trailing twelve month operating cash flow for LMAT is currently 58.04, higher than 93.47% of US stocks with positive operating cash flow.
- LMAT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 11.63% of US stocks.
- If you're looking for stocks that are quantitatively similar to LEMAITRE VASCULAR INC, a group of peers worth examining would be ATRI, MMSI, SHYF, INTT, and KVHI.
- Visit LMAT's SEC page to see the company's official filings. To visit the company's web site, go to www.lemaitre.com.
LMAT Valuation Summary
- LMAT's price/earnings ratio is 65.5; this is 171.78% higher than that of the median Healthcare stock.
- Over the past 202 months, LMAT's EV/EBIT ratio has gone down 233.3.
Below are key valuation metrics over time for LMAT.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| LMAT | 2023-05-23 | 8.0 | 4.9 | 65.5 | 49.2 |
| LMAT | 2023-05-22 | 8.1 | 5.0 | 66.5 | 49.9 |
| LMAT | 2023-05-19 | 8.2 | 5.0 | 66.9 | 50.2 |
| LMAT | 2023-05-18 | 8.3 | 5.1 | 67.8 | 50.9 |
| LMAT | 2023-05-17 | 8.4 | 5.2 | 68.5 | 51.4 |
| LMAT | 2023-05-16 | 8.4 | 5.2 | 69.1 | 51.9 |
LMAT Growth Metrics
- Its year over year revenue growth rate is now at 17.38%.
- Its year over year net cashflow from operations growth rate is now at -14.98%.
- Its 5 year net income to common stockholders growth rate is now at 51.12%.
The table below shows LMAT's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 160.2 | 26.357 | 21.184 |
| 2022-06-30 | 159.54 | 33.09 | 22.232 |
| 2022-03-31 | 158.102 | 33.739 | 27.016 |
| 2021-12-31 | 154.424 | 35.102 | 26.907 |
| 2021-09-30 | 152.469 | 44.198 | 27.765 |
| 2021-06-30 | 150.517 | 44.235 | 28.774 |
LMAT's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- LMAT has a Quality Grade of B, ranking ahead of 84.43% of graded US stocks.
- LMAT's asset turnover comes in at 0.589 -- ranking 73rd of 186 Medical Equipment stocks.
- ISRG, SYK, and KIDS are the stocks whose asset turnover ratios are most correlated with LMAT.
The table below shows LMAT's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.589 | 0.655 | 0.287 |
| 2021-06-30 | 0.597 | 0.649 | 0.299 |
| 2021-03-31 | 0.530 | 0.653 | 0.241 |
| 2020-12-31 | 0.542 | 0.654 | 0.220 |
| 2020-09-30 | 0.548 | 0.657 | 0.196 |
| 2020-06-30 | 0.574 | 0.677 | 0.177 |
LMAT Price Target
For more insight on analysts targets of LMAT, see our LMAT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $66.14 | Average Broker Recommendation | 1.5 (Moderate Buy) |
LeMaitre Vascular, Inc. (LMAT) Company Bio
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.
Latest LMAT News From Around the Web
Below are the latest news stories about LEMAITRE VASCULAR INC that investors may wish to consider to help them evaluate LMAT as an investment opportunity.
Is This Healthcare Stock a Buy for Dividend Growth Investors?One stock that has worked out considerably well for its investors is LeMaitre Vascular (NASDAQ: LMAT). Let's elaborate on the medical device company's fundamentals and valuation to make a judgment. LeMaitre Vascular has stayed the course in vascular medical devices and resisted the urge to branch out into the unknown. |
LeMaitre Vascular goes ex-dividend tomorrow
|
Q1 2023 Aziyo Biologics Inc Earnings CallQ1 2023 Aziyo Biologics Inc Earnings Call |
What Makes LeMaitre Vascular (LMAT) a Strong Momentum Stock: Buy Now?Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out. |
Is Now The Time To Look At Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?LeMaitre Vascular, Inc. ( NASDAQ:LMAT ), might not be a large cap stock, but it led the NASDAQGM gainers with a... |
LMAT Price Returns
| 1-mo | -0.27% |
| 3-mo | 28.67% |
| 6-mo | 41.79% |
| 1-year | 43.62% |
| 3-year | 150.39% |
| 5-year | 97.14% |
| YTD | 41.76% |
| 2022 | -7.40% |
| 2021 | 25.10% |
| 2020 | 14.09% |
| 2019 | 53.77% |
| 2018 | -25.13% |
LMAT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching LMAT
Here are a few links from around the web to help you further your research on Lemaitre Vascular Inc's stock as an investment opportunity:Lemaitre Vascular Inc (LMAT) Stock Price | Nasdaq
Lemaitre Vascular Inc (LMAT) Stock Quote, History and News - Yahoo Finance
Lemaitre Vascular Inc (LMAT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...